Company profile: GlycoFi
1.1 - Company Overview
Company description
- Provider of biotherapeutic development based on glycan optimization technology and a yeast-based glycosylation protein manufacturing process, aiming to build its own pipeline of therapeutic proteins and partner with other drug-makers to develop products.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to GlycoFi
Heppe Medical Chitosan
HQ: Germany
Website
- Description: Provider of pure biopolymers and nanoparticles based on chitin and chitosan for cosmetic and pharmaceutical applications, offering GMP chitosan and chitosan derivatives; microfluidics for chitosan-TPP nanoparticles for drug delivery; 3D bioprinted chitosan networks for dental use; cisplatin-chitosan microparticles for breast implants; and biodegradable antibacterial chitosan-based masks.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Heppe Medical Chitosan company profile →
NuAire
HQ: United States
Website
- Description: Provider of ergonomic laboratory equipment for Life Science, Clinical, and Industrial research applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuAire company profile →
Modular Genetics
HQ: United States
Website
- Description: Provider of an automated gene engineering system that accelerates product development and reduces costs by enabling simultaneous development of multiple products, and engineered microorganisms that synthesize chemicals from renewable raw materials such as sugar to support a renewable materials-based economy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Modular Genetics company profile →
GenVault
HQ: United States
Website
- Description: Provider of sample management solutions for disease diagnosis, research, identification and criminal investigations, offering secure, GxP-compliant biorepository storage for over 60,000,000 samples (ambient to cryogenic), specialized transport and lab relocation with full chain-of-custody and GxP/USDOT compliance, and end-to-end bioinventory support—accession, monitoring, tracking, reporting and disposal—via a secure online portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenVault company profile →
Dualsystems Biotech
HQ: Switzerland
Website
- Description: Provider of proteomic services for industry and academia, offering mass spectrometry-based proteomics and ligand-receptor interaction platforms: LRC-TriCEPS to identify interactions on living cells for drug discovery and receptor identification, and HATRIC-LRC to find receptors for orphan ligands. Swiss biotech founded in 2000 with yeast two-hybrid technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dualsystems Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for GlycoFi
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to GlycoFi
2.2 - Growth funds investing in similar companies to GlycoFi
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for GlycoFi
4.2 - Public trading comparable groups for GlycoFi
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →